Evidence map›Paper›PMID 34301763›Full record

ArticleCancer research2021

ATR/ATM-Mediated Phosphorylation of BRCA1 T1394 Promotes Homologous Recombinational Repair and G

Tzeh K Foo, Gabriele Vincelli, Eric Huselid, Joonyoung Her, Haiyan Zheng, Srilatha Simhadri, Meiling Wang, Yanying Huo, Tao Li, Xiaochun Yu and 4 more

Open access · bronzeAbstract read
In one paragraph

Article in Cancer research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 26 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. PAX-Interacting Protein 1 (PTIP) Promotes Apoptosis.Journal of cellular signaling · 2025
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Olaparib-ResistantCells · 2023
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 4 institutions in 2 countries.

Tzeh K FooDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey.ORCID 0000-0003-0168-7054
Gabriele VincelliDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Eric HuselidDepartment of Molecular Biology and Biochemistry, Division of Life Sciences, Rutgers School of Arts and Sciences, Rutgers, The State University of New Jersey, Piscataway, New Jersey.ORCID 0000-0002-7954-702X
Joonyoung HerDepartment of Molecular Biology and Biochemistry, Division of Life Sciences, Rutgers School of Arts and Sciences, Rutgers, The State University of New Jersey, Piscataway, New Jersey.ORCID 0000-0002-8674-2317
Haiyan ZhengMass Spectrometry Facility, Center for Advanced Biotechnology and Medicine, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Srilatha SimhadriDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Meiling WangDepartment of Biochemistry and Structural Biology, Long School Of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas.
Yanying HuoDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey.ORCID 0000-0003-4747-4951
Tao LiDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey.
Xiaochun YuSchool of Life Sciences, Westlake University, Hangzhou, China.
Hong LiCenter for Advanced Proteomics Research, Rutgers Biomedical and Health Sciences, New Jersey Medical School, Rutgers Cancer Institute of New Jersey-Newark, Rutgers, The State University of New Jersey, Newark, New Jersey.
Weixing ZhaoDepartment of Biochemistry and Structural Biology, Long School Of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas.ORCID 0000-0001-5746-3696
Samuel F BuntingDepartment of Molecular Biology and Biochemistry, Division of Life Sciences, Rutgers School of Arts and Sciences, Rutgers, The State University of New Jersey, Piscataway, New Jersey.
Bing XiaDepartment of Radiation Oncology, Rutgers Cancer Institute of New Jersey and Robert Wood Johnson Medical School, New Brunswick, New Jersey. xiabi@cinj.rutgers.edu.
Johnson University · USRutgers, The State University of New Jersey · USThe University of Texas Health Science Center at San Antonio · USWestlake University · CN

Funding

TRANSCRIPTIONAL PROFILINGP30CA072720 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI Tracie Saunders · 1997 to 2026
$94.5M
Project 4: The BRCA Network in Medulloblastoma Responses to Replication StressP01CA250957 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI XIA, BING · 2021 to 2025
$11.3M
Rutgers Mass Spectrometry Core for Integrative Neuroscience ResearchP30NS046593 · NINDS · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI LI, HONG, LOBEL, PETER · 2004 to 2018
$9.9M
Role of PALB2 in the DNA Damage Response and Cancer SuppressionR01CA138804 · NCI · UNIV OF MED/DENT NJ-R W JOHNSON MED SCH · PI XIA, BING · 2009 to 2024
$5.5M
Targeting Autophagy in Hereditary Breast CancerR01CA188096 · NCI · RBHS -CANCER INSTITUTE OF NEW JERSEY · PI WHITE, EILEEN P., XIA, BING · 2015 to 2019
$2.4M
Control of Commitment Steps in Mammalian Homologous RecombinationR01CA190858 · NCI · RUTGERS, THE STATE UNIV OF N.J. · PI BUNTING, SAMUEL · 2015 to 2021
$2.1M
Genome Maintenance via the BRCA-RAD54 Axis.R01GM141091 · NIGMS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ZHAO, WEIXING WILSON · 2021 to 2025
$1.8M
Regulation of DNA replication kinetics by BRCA2 after DNA damageR01CA262227 · NCI · RUTGERS BIOMEDICAL AND HEALTH SCIENCES · PI XIA, BING · 2021 to 2025
$1.7M
Orbitrap Fusion Lumos Tribrid MS System for Proteomics Research at Rutgers Newark CampusS10OD025047 · OD · RBHS-NEW JERSEY MEDICAL SCHOOL · PI LI, HONG · 2018 to 2018
$1.1M
NCI NIH HHS P01 CA250957NCI NIH HHS P30 CA072720NCI NIH HHS R01 CA138804NCI NIH HHS R01 CA188096NCI NIH HHS R01 CA190858NCI NIH HHS R01 CA262227NIGMS NIH HHS R01 GM141091NIH HHS S10 OD025047NINDS NIH HHS P30 NS046593
6 · The paper itself

Abstract

BRCA1 maintains genome integrity and suppresses tumorigenesis by promoting homologous recombination (HR)-mediated repair of DNA double-strand breaks (DSB) and DNA damage-induced cell-cycle checkpoints. Phosphorylation of BRCA1 by ATM, ATR, CHK2, CDK, and PLK1 kinases has been reported to regulate its functions. Here we show that ATR and ATM-mediated phosphorylation of BRCA1 on T1394, a highly conserved but functionally uncharacterized site, is a key modification for its function in the DNA damage response (DDR). Following DNA damage, T1394 phosphorylation ensured faithful repair of DSBs by promoting HR and preventing single-strand annealing, a deletion-generating repair process. BRCA1 T1394 phosphorylation further safeguarded chromosomal integrity by maintaining the G

Indexed as

Recombinational DNA RepairAmino AcidsAmino Acid SequenceAnimalsAtaxia Telangiectasia Mutated ProteinsBRCA1 ProteinCell Line, TumorDisease Models, AnimalDNA DamageDrug Resistance, NeoplasmG2 Phase Cell Cycle CheckpointsHumansMiceMice, TransgenicModels, BiologicalPhosphorylationAmino AcidsAtaxia Telangiectasia Mutated ProteinsATM protein, humanATR protein, humanBRCA1 ProteinBRCA1 protein, human

Identifiers

PMID34301763
PMCPMC8448966
OpenAlexW3186354188

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.